Arcus Biosciences, Inc. (RCUS) short interest & options flow
NYSEArcus Biosciences has recovered sharply from the $22.51 trough of a week ago, and the rebound has arrived alongside a wave of analyst activity that is both unusual in its volume and uniform in its direction. The stock closed Tuesday at $23.75, up 7.3% on the day and 5.5% on the week. Among its closest correlated peers, the median weekly gain was 3.6%, so Arcus outpaced the group…
RCUS cost to borrow surges to 0.52% — up 726% in one week — after recent biotech analyst upgrades.
- Market cap
- $2.51B
- Next earnings
- 22 Feb 2027
Key data as of 14 Nov 2026
RCUS news and analysis
RSSNo long-form analysis yet for RCUS. Pulse alerts and the live data picture are available on ORTEX.
Open RCUS on ORTEX →Want the live picture for RCUS?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for RCUS — free to start on ORTEX.
Sign up for free →Open RCUS on ORTEX